Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic Syndromes
Clinical trial NCT07672769 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07672769
- Sponsor
- Faron Pharmaceuticals Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-01
- Primary completion
- 2027-11-30
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.